[Effect of epsilon-aminocaproic acid and kurantil on gastric secretory activity].
D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D002908:Chronic Disease; D003864:Depression, Chemical; D004176:Dipyridamole / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D005756:Gastritis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy / Q000503:physiopathology
D000614:Aminocaproates; D004176:Dipyridamole; D015119:Aminocaproic Acid
Vliianie épsilon-aminokapronovoĭ kisloty i kurantila na sekretornuiu deiatel'nost' zheludka.